243 related articles for article (PubMed ID: 23684514)
1. Elevated C-reactive protein and cognitive deficits in individuals with bipolar disorder.
Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
J Affect Disord; 2013 Sep; 150(2):456-9. PubMed ID: 23684514
[TBL] [Abstract][Full Text] [Related]
2. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results.
Dittmann S; Seemüller F; Schwarz MJ; Kleindienst N; Stampfer R; Zach J; Born C; Bernhard B; Fast K; Grunze H; Engel RR; Severus E
Bipolar Disord; 2007; 9(1-2):63-70. PubMed ID: 17391351
[TBL] [Abstract][Full Text] [Related]
3. Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.
Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yolken R
Schizophr Res; 2012 Jan; 134(1):83-8. PubMed ID: 22048011
[TBL] [Abstract][Full Text] [Related]
4. Cognitive functioning in schizophrenia and bipolar disorder: comparison of performance on the Repeatable Battery for the Assessment of Neuropsychological Status.
Dickerson F; Boronow JJ; Stallings C; Origoni AE; Cole SK; Yolken RH
Psychiatry Res; 2004 Nov; 129(1):45-53. PubMed ID: 15572184
[TBL] [Abstract][Full Text] [Related]
5. The association among smoking, HSV-1 exposure, and cognitive functioning in schizophrenia, bipolar disorder, and non-psychiatric controls.
Dickerson F; Adamos MB; Katsafanas E; Khushalani S; Origoni A; Savage CLG; Schroeder J; Schweinfurth LAB; Stallings C; Sweeney K; Yolken R
Schizophr Res; 2016 Oct; 176(2-3):566-571. PubMed ID: 27262384
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein is elevated in schizophrenia.
Dickerson F; Stallings C; Origoni A; Vaughan C; Khushalani S; Yang S; Yolken R
Schizophr Res; 2013 Jan; 143(1):198-202. PubMed ID: 23218564
[TBL] [Abstract][Full Text] [Related]
7. Repeatable battery for the assessment of neuropsychological status as a screening test in schizophrenia, II: convergent/discriminant validity and diagnostic group comparisons.
Hobart MP; Goldberg R; Bartko JJ; Gold JM
Am J Psychiatry; 1999 Dec; 156(12):1951-7. PubMed ID: 10588410
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to Toxoplasma gondii and cognitive functioning in schizophrenia, bipolar disorder, and nonpsychiatric controls.
Dickerson F; Stallings C; Origoni A; Katsafanas E; Schweinfurth L; Savage C; Khushalani S; Yolken R
J Nerv Ment Dis; 2014 Aug; 202(8):589-93. PubMed ID: 25010110
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia.
Dickerson F; Stallings C; Origoni A; Boronow J; Yolken R
Schizophr Res; 2007 Jul; 93(1-3):261-5. PubMed ID: 17490859
[TBL] [Abstract][Full Text] [Related]
10. Use of the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) to investigate group and gender differences in schizophrenia and bipolar disorder.
Gogos A; Joshua N; Rossell SL
Aust N Z J Psychiatry; 2010 Mar; 44(3):220-9. PubMed ID: 20050718
[TBL] [Abstract][Full Text] [Related]
11. Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.
Dickerson FB; Boronow JJ; Stallings C; Origoni AE; Cole S; Krivogorsky B; Yolken RH
Biol Psychiatry; 2004 Mar; 55(6):588-93. PubMed ID: 15013827
[TBL] [Abstract][Full Text] [Related]
12. The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis.
Johnsen E; Fathian F; Kroken RA; Steen VM; Jørgensen HA; Gjestad R; Løberg EM
BMC Psychiatry; 2016 Mar; 16():60. PubMed ID: 26973142
[TBL] [Abstract][Full Text] [Related]
13. Study on the Correlation between Hcy and Hs-CRP Levels and Cognitive Function in Patients with Bipolar Disorder and Borderline Personality Disorder.
Wang C; Lv L; Xin B; Li N; Wang J; An C; Zhang K
Actas Esp Psiquiatr; 2024 Apr; 52(2):99-106. PubMed ID: 38622012
[TBL] [Abstract][Full Text] [Related]
14. Cognitive functioning in recent onset psychosis.
Dickerson F; Stallings C; Vaughan C; Origoni A; Khushalani S; Dickinson D; Medoff D
J Nerv Ment Dis; 2011 Jun; 199(6):367-71. PubMed ID: 21629013
[TBL] [Abstract][Full Text] [Related]
15. Impaired functioning in euthymic patients with bipolar disorder--HSV-1 as a predictor.
Gerber SI; Krienke UJ; Biedermann NC; Grunze H; Yolken RH; Dittmann S; Langosch JM
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jan; 36(1):110-6. PubMed ID: 21945379
[TBL] [Abstract][Full Text] [Related]
16. Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder.
Sanchez-Autet M; Arranz B; Safont G; Sierra P; Garcia-Blanco A; de la Fuente L; Garriga M; García-Portilla MP
J Affect Disord; 2018 Mar; 229():95-104. PubMed ID: 29306698
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder.
Dickerson F; Stallings C; Origoni A; Boronow J; Yolken R
Prog Neuropsychopharmacol Biol Psychiatry; 2007 May; 31(4):952-5. PubMed ID: 17391822
[TBL] [Abstract][Full Text] [Related]
18. Inflammatory markers and their possible effects on cognitive function in women with posttraumatic stress disorder.
Imai R; Hori H; Itoh M; Lin M; Niwa M; Ino K; Ogawa S; Ishida M; Sekiguchi A; Matsui M; Kunugi H; Akechi T; Kamo T; Kim Y
J Psychiatr Res; 2018 Jul; 102():192-200. PubMed ID: 29684628
[TBL] [Abstract][Full Text] [Related]
19. The impact of homocysteine levels on cognition in euthymic bipolar patients: a cross-sectional study.
Dittmann S; Seemüller F; Grunze HC; Schwarz MJ; Zach J; Fast K; Born C; Dargel S; Engel RR; Bernhard B; Möller HJ; Riedel M; Severus WE
J Clin Psychiatry; 2008 Jun; 69(6):899-906. PubMed ID: 18399726
[TBL] [Abstract][Full Text] [Related]
20. A longitudinal study of cognitive functioning in schizophrenia: clinical and biological predictors.
Dickerson F; Schroeder J; Stallings C; Origoni A; Katsafanas E; Schwienfurth LA; Savage CL; Khushalani S; Yolken R
Schizophr Res; 2014 Jul; 156(2-3):248-53. PubMed ID: 24827555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
